Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Viking Global Investors LP reported a 18.80% stake in Adaptive Biotechnologies Corporation (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Viking Global Investors LP reported a 18.80% stake in Adaptive Biotechnologies Corporation, 29,993,708 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 18.80%
- Shares
- 29,993,708
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 18.80% | 29,993,708 |
| VIKING GLOBAL PERFORMANCE LLC | 13.80% | 22,002,189 |
| Viking Global Equities II LP | 0.30% | 440,046 |
| Viking Global Equities Master Ltd. | 13.50% | 21,562,143 |
| Viking Long Fund GP LLC | 5.00% | 7,991,519 |
| Viking Long Fund Master Ltd. | 5.00% | 7,991,519 |
| HALVORSEN OLE ANDREAS | 18.80% | 29,993,708 |
| Shabet Rose Sharon | 18.80% | 29,993,708 |
Source
Related
- Adaptive Biotechnologies Corporation
- Viking Global Investors LP
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Rubinstein Julie · Oct 21, 2026
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Bobulsky Susan · Oct 8, 2026